VALENCIA, Calif., Sept. 14 /PRNewswire-FirstCall/ -- MannKind Corporation (Nasdaq: MNKD - News), focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will present at upcoming conferences to provide an update on the Company.
